Landscapes / Companies
Vor Biopharma not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 3 in all
Trials
2 active
6 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Receptor molecules, native or modified |
Approved in China | Mar 2027Phase 3 trial completes | |||
| How it works | A decoy protein that soaks up a signal molecule before it can reach the body's cells | ||||
| Next date | Mar 2027 · Phase 3 trial completes | ||||
| Also tested for | Generalized Myasthenia Gravis, Primary Sjogren's Disease | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021